Back to list

Somatus

Provider of concierge kidney care intended to delay or prevent the progression of chronic kidney disease to ESRD.
Provider of concierge kidney care intended to delay or prevent the progression of chronic kidney disease to ESRD.
Clinics/Outpatient Services 📍 McLean, VA Founded 2016
Current Valuation
$2.6B
as of 2022-Q1
UNICORN

QL Price

$2.4B
-8% vs last round
QuantLogix's current estimate for Somatus, published 2026-09-11 — below the last disclosed round of $2.6B (2022-Q1).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round $2.6B 2022-Q1 weight 0.05
Secondary market print $2.3B 2026-06-27 weight 0.63
How this price has held up
No round has priced for Somatus since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-11 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Somatus →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Somatus, 2026-09-11 (f6af118398cfbd7d). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Somatus going public?
No. Somatus is private and has not filed to go public. There is no S-1 on file.
What is Somatus' valuation in 2026?
Somatus is valued at $2.6B as of 2022-Q1, set by its Series E ($325M, Feb 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Somatus filed an S-1?
No public S-1 is on file for Somatus.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
2016
HQ
McLean, VA
Employees
804
Total Raised
$490.12M
Last Round
Series E — $325M (Feb 2022)
IPO Status
private

Fundraising Status

Series E · $325M · 4y 7mo ago
privateTotal raised $490.12M

Secondary Market

Implied price / share
$800
Last round price / share
$872.63
vs last round
-8.3%
Last round price vs secondary price
Last round vs current secondary price per share$873Last round$800Current
Secondary price return by period
Secondary market period returns3-month0.0%6-month0.0%1-year0.0%All-time0.0%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series E$325MFeb 2022$2.6B

Talent Signal

No public careers page or job board could be found for Somatus as of 2026-08-17. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Health CareHealth DiagnosticsHospitalMedicalWellness
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.